{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:48:20Z","timestamp":1778852900638,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>This study presents a case of brain\u2013lung\u2013thyroid syndrome caused by a pathogenic variant in the <jats:italic>NKX2-1<\/jats:italic> gene, which is characterized by interstitial lung disease. A 7-month-old female infant was hospitalized for over half a month for cyanosis. The full-term infant developed respiratory distress syndrome soon after delivery, requiring mechanical ventilation, and was diagnosed with congenital hypothyroidism. In the first seven months of life, the infant also showed hypotonia, feeding difficulties, and developmental delays. Chest CT findings demonstrated generalized ground-glass opacities in both lung fields. A heterozygous pathogenic variant of the <jats:italic>NKX2-1<\/jats:italic> gene [NM_001079668.3:c.583C&amp;gt;T (p.Arg195Trp)] was identified by whole-exome sequencing. The infant received a combination therapy, comprising supplementary thyroxine, nutritional support, high-flow nasal cannula oxygen therapy, and exploratory treatment with hydroxychloroquine. High-flow nasal cannula oxygen therapy was administered after discharge. The patient was followed up for over 2\u2005months, and the patient had changed to low-flow oxygen therapy, although she developed radiographic progression. Studies on hydroxychloroquine for the treatment of interstitial lung diseases are limited. This article describes a case of interstitial lung disease caused by a pathogenic variant in the <jats:italic>NKX2-1<\/jats:italic> gene, whose oxygen demand decreased after treatment with hydroxychloroquine.<\/jats:p>","DOI":"10.3389\/fped.2025.1619722","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:33:03Z","timestamp":1760592783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hydroxychloroquine in an infant with NKX2-1-associated interstitial lung disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Di","family":"Qing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103909","DOI":"10.1016\/j.lpm.2019.06.007","article-title":"Interstitial lung diseases in children","volume":"49","author":"Nathan","year":"2020","journal-title":"Presse Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/archdischild-2012-303143","article-title":"Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate","volume":"102","author":"Gupta","year":"2017","journal-title":"Arch Dis Child"},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/archdischild-2012-303166","article-title":"Genetic testing in children with surfactant dysfunction","volume":"98","author":"Turcu","year":"2013","journal-title":"Arch Dis Child"},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/CS20080068","article-title":"Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung","volume":"116","author":"Boggaram","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"B5","first-page":"1993","article-title":"NKX2-1-related disorders","volume-title":"GeneReviews\u00ae [Internet]","author":"Patel","year":"2014"},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1515\/jpem-2021-0402","article-title":"Growth hormone deficiency in a child with benign hereditary chorea caused by a de novo mutation of the TITF1\/NKX2-1 gene","volume":"35","author":"Trevisani","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.31486\/toj.21.0101","article-title":"Unusual cause of respiratory distress in a term neonate","volume":"22","author":"Mirza","year":"2022","journal-title":"Ochsner J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e19650","DOI":"10.1097\/MD.0000000000019650","article-title":"Combined mutations of NKX2-1 and surfactant protein C genes for refractory low oxyhemoglobin saturation and interstitial pneumonia: a case report","volume":"99","author":"Gu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41390-023-02882-x","article-title":"Functional characterization of two novel NKX2-1 frameshift pathogenic variants that cause pulmonary surfactant dysfunction","volume":"95","author":"Wang","year":"2024","journal-title":"Pediatr Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/children11080904","article-title":"The clinical approach to interstitial lung disease in childhood: a narrative review article","volume":"11","author":"Drob\u0148akov\u00e1","year":"2024","journal-title":"Children (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s0167-4781(97)00210-8","article-title":"Structure of the human NKX2-1 gene","volume":"1396","author":"Hamdan","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.rmed.2017.05.014","article-title":"Heterogeneity of lung disease associated with NK2 homeobox 1 mutations","volume":"129","author":"Nattes","year":"2017","journal-title":"Respir Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/jmedgenet-2013-102248","article-title":"Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum","volume":"51","author":"Thorwarth","year":"2014","journal-title":"J Med Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/humu.24476","article-title":"Rare surfactant-related variants in familial and sporadic pulmonary fibrosis","volume":"43","author":"Sutton","year":"2022","journal-title":"Hum Mutat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/pr.2018.30","article-title":"Mutations in the thyroid transcription factor gene NKX2-1 result in decreased expression of SFTPB and SFTPC","volume":"84","author":"Attarian","year":"2018","journal-title":"Pediatr Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1378\/chest.13-0550","article-title":"Pediatric interstitial lung disease: thyroid transcription factor-1 mutations and their phenotype potpourri","volume":"144","author":"Yonker","year":"2013","journal-title":"Chest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.celrep.2023.112212","article-title":"Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma","volume":"42","author":"Ebisudani","year":"2023","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/pr.2017.217","article-title":"Genetic basis for childhood interstitial lung disease among Japanese infants and children","volume":"83","author":"Hayasaka","year":"2018","journal-title":"Pediatr Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00247-019-04388-3","article-title":"High-resolution computed tomography findings of thyroid transcription factor 1 deficiency (NKX2-1 mutations)","volume":"49","author":"LeMoine","year":"2019","journal-title":"Pediatr Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ppul.26765","article-title":"The significance of multidisciplinary team meetings in diagnosing and managing childhood interstitial lung disease within the RespiRare network","volume":"59","author":"Cassibba","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"210017","DOI":"10.1183\/16000617.0017-2021","article-title":"Lung transplantation for interstitial lung disease","volume":"30","author":"Kapnadak","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ppul.23133","article-title":"Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases","volume":"50","author":"Braun","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-022-02399-2","article-title":"Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease","volume":"17","author":"Griese","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.3390\/ijms24098179","article-title":"ABCA3 deficiency-variant-specific response to hydroxychloroquine","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13256-020-02604-5","article-title":"Hydroxychloroquine, a successful treatment for lung disease in ABCA3 deficiency gene mutation: a case report","volume":"15","author":"Shaaban","year":"2021","journal-title":"J Med Case Rep"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1619722\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:33:04Z","timestamp":1760592784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1619722\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":25,"alternative-id":["10.3389\/fped.2025.1619722"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1619722","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1619722"}}